Search Results - "Vesterhus, M."

Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis by Karlsen, T. H., Vesterhus, M., Boberg, K. M.

“…Summary Background Despite considerable advances over the last two decades in the molecular understanding of cholestasis and cholestatic liver disease, little…”
Get full text

Altered gut microbiota profile in common variable immunodeficiency associates with levels of lipopolysaccharide and markers of systemic immune activation by Jørgensen, S F, Trøseid, M, Kummen, M, Anmarkrud, J A, Michelsen, A E, Osnes, L T, Holm, K, Høivik, M L, Rashidi, A, Dahl, C P, Vesterhus, M, Halvorsen, B, Mollnes, T E, Berge, R K, Moum, B, Lundin, K E A, Fevang, B, Ueland, T, Karlsen, T H, Aukrust, P, Hov, J R

“…Common variable immunodeficiency (CVID) is the most common symptomatic primary immunodeficiency characterized by low immunoglobulin (Ig)G and IgA, and/or IgM…”
Get full text

Serological markers of extracellular matrix remodeling predict transplant‐free survival in primary sclerosing cholangitis by Nielsen, M. J., Thorburn, D., Leeming, D. J., Hov, J. R., Nygård, S., Moum, B., Saffioti, F., Gilja, O. H., Boberg, K. M., Mazza, G., Røsjø, H., Pinzani, M., Karlsen, T. H., Karsdal, M. A., Vesterhus, M.

“…Summary Background Primary sclerosing cholangitis is a progressive liver disease with a remarkably variable course. Biomarkers of disease activity or…”
Get full text

Lack of pancreatic body and tail in HNF1B mutation carriers by Haldorsen, I. S., Vesterhus, M., Ræder, H., Jensen, D. K., Søvik, O., Molven, A., Njølstad, P. R.

“…Aims  Hepatocyte nuclear factor 1B (HNF1B) gene mutation carriers have a systemic disease characterized by congenital malformations in the urogenital tract,…”
Get full text

The gut microbiota in liver transplanted primary sclerosing cholangitis patients is characterized by exacerbated dysbiosis by Kummen, M, Holm, K, Vesterhus, M, Trøseid, M, Melum, E, Aukrust, P, Karlsen, T.H, Hov, J.R

Get full text

Biliary Tract Cancer with or without Primary Sclerosing Cholangitis is Associated with a Raised Enhanced Liver Fibrosis Test Result Compared with PSC Alone by Saffioti, F, Roccarina, D, Vesterhus, M, Hov, J.R, Rosenberg, W, Pinzani, M, Karlsen, T.H, Pereira, S.P, Boberg, K.M, Thorburn, D

Get full text

P1174 : Microbiota-dependent marker trimethylamine-N-oxide (TMAO) is associated with the severity of primary sclerosing cholangitis by Kummen, M, Vesterhus, M, Trøseid, M, Moum, B, Svardal, A, Boberg, K.M, Aukrust, P, Karlsen, T.H, Berge, R.K, Hov, J.R

Get full text

Suppression of bile acid synthesis as a tipping point in the disease course of primary sclerosing cholangitis by Braadland, Peder Rustøen, Schneider, Kai Markus, Bergquist, Annika, Molinaro, Antonio, Lövgren-Sandblom, Anita, Henricsson, Marcus, Karlsen, Tom Hemming, Vesterhus, Mette, Trautwein, Christian, Hov, Johannes Roksund, Marschall, Hanns-Ulrich

“…Farnesoid X receptor (FXR) agonists and fibroblast growth factor 19 (FGF19) analogues suppress bile acid synthesis and are being investigated for their…”
Get full text

Serological Biomarkers of Extracellular Matrix Remodeling Predict Transplant-Free Survival in Primary Sclerosing Cholangitis Patients by Nielsen, M.J, Thorburn, D, Leeming, D.J, Hov, J.R, Moum, B, Saffioti, F, Gilja, O.H, Boberg, K.M, Mazza, G, Pinzani, M, Karlsen, T.H, Karsdal, M.A, Vesterhus, M

Get full text

O082 : The gut microbiota in primary sclerosing cholangitis differs from that of healthy controls and ulcerative colitis patients without biliary disease by Kummen, M, Holm, K, Anmarkrud, J.A, Vesterhus, M, Høivik, M.L, Trøseid, M, Marschall, H.-U, Schrumpf, E, Moum, B, Aukrust, P, Karlsen, T.H, Hov, J.R

Get full text

Autoreactive Iga Antibodies against the Pancreatic Major Glycoprotein 2 are Associated with Primary Sclerosing Cholangitis and Related Biliary Tract Cancer by Jendrek, S.T, Gotthardt, D, Nitzsche, T, Korf, T, Michaels, M.A, Weiss, K.-H, Liaskou, E, Vesterhus, M, Karlsen, T.H, Mindorf, S, Schemmer, P, Bär, F, Schröder, T, Ehlers, M, Hammers, C.M, Komorowski, L, Lehnert, H, Fellermann, K, Derer, S, Hov, J.R, Sina, C

Get full text

P363 ENHANCED LIVER FIBROSIS SCORE PREDICTS TRANSPLANT-FREE SURVIVAL IN PSC INDEPENDENTLY OF THE MAYO RISK SCORE by Vesterhus, M, Hov, J.R, Holm, A, Schrumpf, E, Godang, K, Andersen, I.M, Næss, S, Røsjø, H, Vatn, M, Gilja, O.H, Lund-Johansen, F, Ponsioen, C.Y, Färkkila, M, Moum, B, Ueland, T, Boberg, K.M, Karlsen, T.H

Get full text

O133 NOVEL PROTEIN MARKERS IDENTIFIED IN BILE AND SERUM ARE ASSOCIATED WITH A DIAGNOSIS OF PRIMARY SCLEROSING CHOLANGITIS, DISEASE SEVERITY, AND TRANSPLANT-FREE SURVIVAL by Vesterhus, M, Holm, A, Hov, J.R, Andersen, I.M, Schrumpf, E, Paulsen, V, Bjørnstad, M, Lundin, K, Zweers, S.J.L.B, Vatn, M, Schaap, F.G, Ueland, T, Røsjø, H, Moum, B, Ponsioen, C.Y, Boberg, K.M, Färkkilä, M, Lund-Johansen, F, Karlsen, T.H

Get full text

Secretin-stimulated duodenal markers associated with increased risk for pancreatic ductal adenocarcinoma by Raeder, H, McAllister, F.E, Tjora, E, Bhatt, S, Haldorsen, I, Hu, J, Willems, S.M, Vesterhus, M, ElOuamaari, A, Liu, M, Raeder, M.T.B, Immervoll, H, Hoem, D, Dimsevski, G, Njolstad, P.R, Molven, A, Gygi, S.P, Kulkarni, R.N

Get full text

SAT-089 - Normal liver elasticity values in a healthy population, by age and gender, for two novel elastography systems by Mulabecirovic, A., Vesterhus, M., Mjelle, A., Havre, R.F., Gilja, O.H.

Get full text

Normal liver elasticity values in a healthy population, by age and gender, for two novel elastography systems by Mulabecirovic, A., Vesterhus, M., Mjelle, A., Havre, R.F., Gilja, O.H.

Get full text

DOP14 Proctocolectomy is associated with improved transplant-free survival in patients with primary sclerosing cholangitis: results from a pooled collaborative international study by Mol, B, van Nieuwamerongen, M, Färkkilä, M, Folseraas, T, Boberg, K, Vesterhus, M, Bergquist, A, Bogaards, H, Ponsioen, C

“…Abstract Background It is hypothesized that the gut-liver axis plays a pivotal role in the aetiology of primary sclerosing cholangitis (PSC). Colectomy before…”
Get full text

SAT-395 - The gut microbiota in liver transplanted primary sclerosing cholangitis patients is characterized by exacerbated dysbiosis by Kummen, M., Holm, K., Vesterhus, M., Trøseid, M., Melum, E., Aukrust, P., Karlsen, T.H., Hov, J.R.

Get full text

Clinical and biochemical impact of vitamin B6 deficiency in primary sclerosing cholangitis before and after liver transplantation by Braadland, Peder Rustøen, Bergquist, Annika, Kummen, Martin, Bossen, Lars, Engesæter, Lise Katrine, Reims, Henrik Mikael, Björk, Ida, Grzyb, Krzysztof, Abildgaard, Andreas, Småstuen, Milada Cvancarova, Folseraas, Trine, Trøseid, Marius, Ulvik, Arve, Ueland, Per Magne, Melum, Espen, Line, Pål-Dag, Høivik, Marte Lie, Grønbæk, Henning, Karlsen, Tom Hemming, Vesterhus, Mette, Hov, Johannes Roksund

“…We previously demonstrated that people with primary sclerosing cholangitis (PSC) had reduced gut microbial capacity to produce active vitamin B6 (pyridoxal…”
Get full text

Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis by Hedin, Charlotte Rose Hawkey, Sado, Gina, Ndegwa, Nelson, Lytvyak, Ellina, Mason, Andrew, Montano-Loza, Aldo, Gerussi, Alessio, Saffioti, Francesca, Thorburn, Douglas, Nilsson, Emma, Larsson, Geir, Moum, Bjørn A., van Munster, Kim N., Ponsioen, Cyriel Y., Levy, Cynthia, Nogueira, Nicholas F., Bowlus, Christopher L., Gotlieb, Neta, Shibolet, Oren, Lynch, Kate D., Chapman, Roger W., Rupp, Christian, Vesterhus, Mette, Jørgensen, Kristin K., Rorsman, Fredrik, Schramm, Christoph, Sabino, João, Vermeire, Severine, Zago, Alessandra, Cazzagon, Nora, Marschall, Hanns-Ulrich, Ytting, Henriette, Ben Belkacem, Karima, Chazouilleres, Olivier, Almer, Sven, Bergquist, Annika

“…Few patients with primary sclerosing cholangitis (PSC) and inflammatory bowel diseases (IBDs) are exposed to tumor necrosis factor (TNF) antagonists because of…”
Get full text